A polygenic risk score may predict future breast cancer in patients with early-stage diagnoses

A retrospective study found that the 313-SNP breast cancer polygenic risk score (PRS313) blood test could predict future incidents of breast cancer in women diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup